O. Miyazaki

发表

Preβ1.HDL, a key element of reverse cholesterol transport: its potential as a biomarker

I. Fukamachi, O. Miyazaki, 2010 .

Preb1‑HDL, a key element of reverse cholesterol transport: its potential as

I. Fukamachi, O. Miyazaki, 2010 .

Lipids , Lipoproteins , Cholesteryl Ester Transfer Protein , and Lecithin : Cholesterol Acyltransferase

D. Sviridov, B. Kingwell, P. Nestel, 2004 .

Physical Fitness and Reverse Cholesterol Transport

D. Sviridov, B. Kingwell, P. Nestel, 2004, Arteriosclerosis, thrombosis, and vascular biology.

A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol

T. Iwamoto, H. Yoshida, O. Miyazaki, 2020 .

A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol[S]

T. Iwamoto, H. Yoshida, O. Miyazaki, 2019, Journal of Lipid Research.

Abbreviated title: Immunoassay for preβ1-HDL in plasma

T. Miida, Yasushi Nakamura, S. Hirayama, 2002 .

Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF).

K. Chida, D. Hashimoto, N. Inui, 2011, Clinica chimica acta; international journal of clinical chemistry.

LCAT-dependent conversion rate is a determinant of plasma prebeta1-HDL concentration in healthy Japanese.

Yuji Saito, T. Miida, Yasushi Nakamura, 2004, Clinica chimica acta; international journal of clinical chemistry.

A novel ELISA system for selective measurement of human adiponectin multimers by using proteases.

T. Kadowaki, T. Yamauchi, Hiroyuki Ebinuma, 2006, Clinica chimica acta; international journal of clinical chemistry.

Selective purification and characterization of adiponectin multimer species from human plasma.

T. Kadowaki, A. Tsuchida, T. Yamauchi, 2007, Biochemical and biophysical research communications.

A novel enzyme immunoassay for the measurement of plasma (1 → 3)-β-D-glucan levels.

Takuya Yotani, S. Shiina, O. Miyazaki, 2020, Journal of immunological methods.

Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma[S]

J. Ogihara, T. Kasumi, I. Fukamachi, 2014, Journal of Lipid Research.

Subtraction method for determination of N-terminal connective tissue growth factor

K. Takehara, P. Ng, K. Endo, 2010, Annals of clinical biochemistry.

The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.

Hiroyuki Ebinuma, O. Miyazaki, H. Yago, 2007, Thrombosis research.

The distribution of fasting and non-fasting serum triglyceride levels in Japanese population.

H. Mabuchi, J. Kobayashi, A. Nohara, 2006, Clinica chimica acta; international journal of clinical chemistry.

LCAT-Dependent Conversion of Preβ1-HDL into α-Migrating HDL is Severely Delayed in Hemodialysis Patients

I. Narita, T. Miida, F. Gejyo, 2003 .

Current smokers with hyperlipidemia lack elevated preβ1-high-density lipoprotein concentrations.

T. Miida, S. Hirayama, O. Miyazaki, 2017, Journal of clinical lipidology.

Serum amyloid A (SAA)-induced remodeling of CSF-HDL.

T. Miida, K. Obayashi, Akihiro Takahashi, 2006, Biochimica et biophysica acta.

Delineation of the role of pre-beta 1-HDL in cholesterol efflux using isolated pre-beta 1-HDL.

D. Sviridov, P. Nestel, A. Hoang, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Delineation of the Role of Pre-1-HDL in Cholesterol Efflux Using Isolated Pre-1-HDL

D. Sviridov, P. Nestel, A. Hoang, 2002 .

Serum Apolipoprotein M Levels are Correlated with Biomarkers of Coagulation

K. Tsunekawa, K. Nakajima, H. Sumino, 2016 .

Plasma connective tissue growth factor levels as potential biomarkers of airway obstruction in patients with asthma.

D. Hashimoto, N. Inui, T. Suda, 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling.

T. Miida, K. Nakajima, Y. Ishikawa, 2008, Atherosclerosis.

Analytical performance of a sandwich enzyme immunoassay for pre beta 1-HDL in stabilized plasma.

T. Miida, Yasushi Nakamura, S. Hirayama, 2003, Journal of lipid research.

Prebeta1-HDL is elevated in the fasting state, but markedly reduced postprandially in poorly controlled type 2 diabetic patients.

Y. Aizawa, T. Miida, S. Hirayama, 2009, Clinica chimica acta; international journal of clinical chemistry.

Plasma pre beta1-HDL level is elevated in unstable angina pectoris.

H. Bujo, J. Tashiro, A. Miyazaki, 2009, Atherosclerosis.

Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein.

Atsuo Mori, M. Yamagishi, H. Mabuchi, 2009, Biochemical and biophysical research communications.

A new sandwich enzyme immunoassay for measurement of plasma pre-beta1-HDL levels.

T. Miida, J. Kobayashi, H. Bujo, 2000, Journal of lipid research.

LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients.

I. Narita, T. Miida, F. Gejyo, 2003, Journal of the American Society of Nephrology.

Pre beta1-HDL concentration is a predictor of carotid atherosclerosis in type 2 diabetic patients.

Takashi Miida, Y. Aizawa, T. Miida, 2007, Diabetes care.